Skip to content
Clinical Trials – home

Benzathine Benzylpenicillin: A Comprehensive Guide for Patients

6 / 8
trials open to patients / all trials
6+
Countries

In short

Benzathine Benzylpenicillin, also known as Benzathine Penicillin G, is an antibiotic medication used in various clinical trials to treat different conditions. This article explores the use of this drug in clinical studies, focusing on its effectiveness, dosing, and potential benefits for patients with conditions like syphilis, streptococcal infections, and rheumatic heart disease.

At a glance

Main Uses in Trials
Treatment of early syphilis, streptococcal infections, prevention of rheumatic heart disease
Administration Method
Intramuscular injection, typically 2.4 million units
Dosing Regimens
Single dose or multiple doses over several weeks
Primary Outcomes Measured
Serological response, microbiological eradication, clinical improvement
Comparison Treatments
Oral amoxicillin, oral cefixime
Patient Populations
Adults and children with various infections, including those with HIV
Duration of Studies
Ranging from several months to multiple years for follow-up
Safety Considerations
Monitoring for adverse events, including Jarisch-Herxheimer reaction

What is Benzathine Benzylpenicillin?

Benzathine Benzylpenicillin, also known as Benzathine Penicillin G (BPG), is an antibiotic medication used to treat various bacterial infections. It belongs to the penicillin family of antibiotics, which work by killing bacteria or preventing their growth. This medication is often referred to by other names, including: Penicillin G Benzathine Bicillin Intramuscular Benzathine Penicillin G Benzathine Benzylpenicillin is a long-acting form of penicillin, which means it stays in the body for an extended period after administration.

Conditions Treated

Benzathine Benzylpenicillin is used to treat several bacterial infections, including: Syphilis: This is the most common use of Benzathine Benzylpenicillin. It is particularly effective for early stages of syphilis, including primary, secondary, and early latent syphilis. Streptococcal infections: Including streptococcal pharyngitis (strep throat) in children. Rheumatic heart disease: It is used as a preventive treatment (prophylaxis) for people with this condition. Benzathine Benzylpenicillin is particularly valuable in treating infections in people living with HIV (PLWH), as they often have a higher risk of certain bacterial infections.

Administration and Dosage

Benzathine Benzylpenicillin is typically administered as an intramuscular injection, which means it's injected directly into a muscle. The most common site for injection is the upper, outer quadrant of the buttock. The dosage can vary depending on the condition being treated: For syphilis in adults: The standard dose is often 2.4 million units (MU) given as a single injection. For children: The dose may be adjusted based on weight. For example, in one study, children weighing more than 27kg received 1.2 million units, while those weighing less received 600,000 units. For rheumatic heart disease prevention: Injections may be given at regular intervals, such as every 28 days. It's important to note that the exact dosage and frequency of administration should always be determined by a healthcare professional based on the individual patient's condition and needs.

Effectiveness

Benzathine Benzylpenicillin has been shown to be highly effective in treating various bacterial infections, particularly syphilis. Its effectiveness is typically measured by observing changes in blood test results and symptoms: For syphilis: Treatment success is often defined as a significant decrease (usually 4-fold or greater) in the rapid plasma reagin (RPR) titer, which is a blood test used to diagnose and monitor syphilis. For streptococcal infections: Effectiveness is measured by the eradication of the bacteria from the throat, as confirmed by a throat culture. In some cases, patients may remain "serofast" after treatment, which means their blood tests continue to show positive results even though the infection has been successfully treated. This is an area of ongoing research.

Comparison with Other Treatments

While Benzathine Benzylpenicillin is considered the standard treatment for many bacterial infections, particularly syphilis, researchers are continuously studying alternative treatments: Amoxicillin: In a study comparing Benzathine Penicillin G to oral amoxicillin for treating strep throat in children, both treatments were found to be effective. Cefixime: This oral antibiotic is being studied as a potential alternative to Benzathine Penicillin G for treating syphilis, particularly in cases of penicillin shortages or allergies. Doxycycline: Some studies are investigating the combination of Benzathine Penicillin G with doxycycline for treating syphilis and other sexually transmitted infections. These comparisons are important for developing alternative treatments, especially for patients who may be allergic to penicillin or in situations where Benzathine Penicillin G is not available.

Side Effects and Safety

Like all medications, Benzathine Benzylpenicillin can cause side effects, although not everyone experiences them. Common side effects may include: Pain at the injection site Allergic reactions (in people with penicillin allergy) Jarisch-Herxheimer reaction: This is a reaction that can occur shortly after treatment for syphilis, causing fever, chills, headache, and muscle pain. It's generally not dangerous and resolves on its own. It's important to inform your healthcare provider of any allergies or past reactions to antibiotics before receiving Benzathine Benzylpenicillin. Pregnant individuals should consult with their healthcare provider, as the safety of this medication during pregnancy may depend on the specific situation and stage of pregnancy.

Ongoing Research

Research on Benzathine Benzylpenicillin is ongoing, with several studies focusing on: Optimal dosing strategies, including comparing single-dose treatments to multiple-dose regimens for syphilis. Effectiveness in different populations, such as people living with HIV. Long-term outcomes and the need for retreatment in certain cases. Combination therapies, such as adding doxycycline to the treatment regimen. The relationship between different strains of bacteria (particularly in syphilis) and treatment outcomes. These ongoing studies aim to improve treatment strategies and outcomes for patients receiving Benzathine Benzylpenicillin.

Questions people often ask

Conditions where Benzathine Benzylpenicillin is being studied

Each condition opens its own overview and trial list

Trials with Benzathine Benzylpenicillin

Recruiting trials first

See all 8 →
Quick filters
  • Participants:Adults
  • Participants:All ages
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.